Table 3. Univariate analysis of survival.

Variable	Mean survival time Month (±SE)	95% CI(Month)	P
Age (years)			0.806
<60	39.6(5.3)	29.3–50.0
≥60	41.6(3.4)	35.0–48.2
Gender
Male	41.0(3.3)	34.5–47.4	0.962
Female	40.7(5.7)	30.0–51.8
Tumor site			0.362
Gastric cardia	36.4 (5.3)	26.0–46.9
Non-cardia	42.0 (3.3)	35.6–48.4
Stage of disease			<0.001
I–II	52.0(4.2)	43.7–60.3
III–IV	32.7 (3.4)	26.1–39.4
Tumor status (p)			0.001
T1-T2	65.5 (6.7)	52.4–78.5
T3-T4	37.3 (2.9)	31.6–43.0
Node status			<0.001
Negative	55.8 (2.9)	27.4–40.5
Positive	34.0 (3.3)	50.0–61.5
Distant metastasis			0.120
No	25.0 (6.6)	12.0–38.0
Yes	41.8(3.0	36.0–47.6
MiR-486–5p			0.002
High expression	55.8 (4.1)	47.7–63.9
Low/unchanged	34.0 (3.3)	27.4–40.5
Tumor size (cm)			0.004
≥10	25.1 (4.8)	15.6–34.5
<10	43.9 (3.1)	35.4–46.6
Depth of tumor invasion			0.013
Mucosa, submucosa, muscularis propria, subserosa	30.3(4.5)	21.5–39.1
Penetration of serosa, adjacent structures	45.1(3.4)	38.5–51.8